Fountain Life, a provider of advanced diagnostics and preventative healthcare, has acquired health data tech firm LifeOmic, which will become the backbone of Fountain Life’s offerings. The move bolsters Fountain Life’s ability to deliver data-driven healthcare services. The combined expertise will aid in improving accuracy of programmes, reaching a wider audience and developing new interventions.
Anti-Cancer Mechanisms of Small Molecule Drugs Predicted by DeepTarget
Identifying the mechanisms of action driving a drug’s anti-cancer efficacy is critical for identifying optimal biomarkers, indications, and combinations for clinical success. Yet, systematically identifying
